OMEGA-3
Fish Oil vs Algae
Source, EPA/DHA labels, dietary preferences and value.
Compare →Evidence review
Why Omega-3 Trial Results Look Mixed
Dose, formulation and population explain much of the disagreement between large trials.
The short answer
Large omega-3 trials have reached different conclusions largely because they used different doses, different formulations (EPA-only prescription products vs EPA + DHA mixtures) and different populations. The clearest, most consistent effect is triglyceride lowering at high doses.
Key takeaways
- Triglyceride lowering at high doses is well established.
- Cardiovascular outcome trials differ in dose and formulation.
- Prescription omega-3 medicines aren’t the same as supplements.
Dose and formulation
Some trials used about 1 g/day of mixed EPA + DHA; others used 4 g/day of a purified prescription EPA product. These are not interchangeable, and outcomes differed.
Who was studied
Trials enrolled different populations — generally healthy adults, people with diabetes, or people with elevated triglycerides and existing cardiovascular risk — which affects what benefit is possible to detect.
What this means when reading labels
Over-the-counter supplements typically deliver far less EPA + DHA than the high-dose prescription products used in some trials. Compare the EPA + DHA per serving, and discuss medical uses with a clinician.
Sources & references
- Omega-3 Fatty Acids: Fact Sheet for Health Professionals. NIH Office of Dietary Supplements. ods.od.nih.govGovernment
SuppScout links to primary and authoritative sources wherever possible. See our editorial policy for how sources are selected and how corrections are handled.
This page is educational and is not medical advice. Talk to a healthcare professional before starting a supplement, especially if you have a medical condition, take medications, or are pregnant or breastfeeding.